# Trial Of Double Umbilical Cord Blood Transplantation

> **NCT00763490** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 20 (actual)

## Conditions studied

- Hematological Malignancies

## Interventions

- **PROCEDURE:** Full intensity, double umbilical cord, stem cell transplant
- **DRUG:** Flu/Bu4 conditioning regimen
- **RADIATION:** Total Lymphoid Irradiation (TLI)
- **DRUG:** Graft versus Host Disease prevention (GVHD prophylaxis)
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT00763490
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2013-03
- **Final completion:** 2015-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763490, "Trial Of Double Umbilical Cord Blood Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00763490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*